Effectiveness and safety assessment of drospirenone/ethinyl estradiol tablet in treatment of PCOS patients: a single center, prospective, observational study

• Main Authors: Li Li (Author), Ruiqin Zhang (Author), Jing Zeng (Author), Hu Ke (Author), Xiuhong Peng (Author), Liying Huang (Author), Hongmei Zhang (Author), Zhijing Chen (Author), Tian Tian Li (Author), Qiuxiao Tan (Author), Ying Yang (Author), Xiaofang Li (Author), Xin Li (Author)
• Format: Book
• Published: BMC, 2020-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background To investigate the effectiveness and safety of 3 mg drospirenone and 20 μg ethinyl estradiol tablet (3 mg DRSP/20 μg EE) in the treatment of polycystic ovary syndrome (PCOS). Methods This single center, prospective observational study was conducted in 140 patients with PCOS. They...